TrialHepatology (Baltimore, Md.)2019

Liver Complications Following Treatment of Hematologic Malignancy With Anti-CD22-Calicheamicin (Inotuzumab Ozogamicin).

George B McDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.